{
    "id": "correct_foundationPlace_00030_0",
    "rank": 97,
    "data": {
        "url": "https://www.analysisgroup.com/",
        "read_more_link": "",
        "language": "en",
        "title": "Economic Consulting & Strategy",
        "top_image": "https://www.analysisgroup.com/Resources/images/og_logo.png",
        "meta_img": "https://www.analysisgroup.com/Resources/images/og_logo.png",
        "images": [
            "https://www.analysisgroup.com/globalassets/about/logo.png",
            "https://www.analysisgroup.com/Resources/images/progress.gif",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/gentzkow_matthew.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/managing-principals/chapsal_antoine.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/mordecai_david.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/managing-principals/kindler_lauren.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/tucker_catherine.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/justin_mclean.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/eden_lorraine.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/weber_steven.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/tufano_peter.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/kirk-fair_rebecca.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/senior-adivsors/giles_tim.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/morrison_ed.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/wei_lee-jen.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/christensen_l.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/erdem_tulin.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/mortimer_richard.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/barnett_arnold.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/gissiner_steven.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/managing-principals/lehmann_jee-yeon.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/navarro_robert.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/managing-principals/cliff_michael.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/vice-presidents/glowka_maja.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/wermers_russell.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/principals/nellesen_dave.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/chevalier_judy.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/managing-principals/rice_brad.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/haas-wilson_deborah.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/peter-golder.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/navathe_amol.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/cohen_jeffrey.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/wilks_jeff.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/managing-principals/mathur_divya.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/pierre_cremieux.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/hitscherich_donna.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/rothman_dov.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/dranove_david.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/willett_joseph.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/good_n.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/principals/marnie_moore.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/noe_christopher.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/mulhern_carla.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/hart_oliver.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/crew_n.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/goodstein_ronald.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/joel_peress2.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/principals/royer_jimmy.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/hochberg_yael.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/wohlgenant_m.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/managing-principals/darling_pavel.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/hauser_john.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/howell_sabrina.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/goodwin_barry.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/managing-principals/okie_andrea.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/piggott_n.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/vice_presidents/schatzki_todd.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/zenner_marc.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/hubbard_rg.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/signorovitch_james.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/kahn_barbara.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/grabowski_david.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/pike_crystal.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/robert-platt.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/vice_presidents/davis_ted.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/zervas_georgios.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/jena_anupam.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/managing-principals/pinheiro_lisa3.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/allen_lewis.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/bruce_deal.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/senior-adivsors/slottje_daniel.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/porten_charles.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/kamerick_eileen.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/powers_kevin.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/principals/resch_jessica.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/knittel_christopher.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/managing_principals/decter_adam.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/amir_on.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/affiliated-experts/grennan_matthew.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/keller_punam.jpg",
            "https://www.analysisgroup.com/globalassets/experts-and-consultants/senior-adivsors/dave_sosa.jpg",
            "https://www.analysisgroup.com/globalassets/content/experts_and_staff/affiliated_experts/prince_jeffrey.jpg",
            "https://www.analysisgroup.com/Resources/images/progress.gif"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Analysis Group provides economic, financial and strategy consulting to law firms, corporations & government agencies. Learn more about our services.",
        "meta_lang": "",
        "meta_favicon": "",
        "meta_site_name": "",
        "canonical_link": "https://www.analysisgroup.com/",
        "text": "Professor Gentzkow specializes in applied microeconomics, empirical industrial organization, and political economy, with a focus on the media, technology, retail, and health care industries. He studies the economic forces driving the creation of media products; competition in media markets; the changing nature and role of media in the digital environment; and the effects of media on education, ideological diversity, and civic engagement. His work has examined the welfare effects of social media networks and how information is disseminated online. Professor Gentzkow’s research has also involved the analysis of complex datasets of consumer purchases to study consumer product pricing, consumer brand preferences, and brand price premiums. He has presented his work to the US Department of Justice, Federal Trade Commission, and Federal Communications Commission.\n\nProfessor Gentzkow has published in numerous prominent economic journals and has appeared frequently in major media such as The New York Times, The Wall Street Journal, The Economist, The Washington Post, and NPR. His awards include the John Bates Clark Medal, given by the American Economic Association to the American economist under 40 judged to have made the most significant contributions to economic thought and knowledge. He is a research associate at the National Bureau of Economic Research and a member of its Industrial Organization Program steering committee, and a senior fellow at the Stanford Institute for Economic Policy Research. Professor Gentzkow has received a fellowship and grants from the Alfred P. Sloan Foundation, as well as various grants from the National Science Foundation.\n\n)\n\nDr. Chapsal is an economist who specializes in empirical and theoretical industrial organization. He has provided economic expertise in a large number of high-profile cases involving mergers, cartels, information exchanges, abuses of dominant positions, regulation, intellectual property matters, and damages quantifications. Recent examples include the Lafarge/Holcim and Fnac/Darty mergers, as well as airfreight, cathode ray tube, and elevator cartel cases. Dr. Chapsal has also assisted various firms in designing optimized pricing strategies and dealing with policy issues. His reports have been presented to the competition authorities of France, Germany, Austria, and South Africa; the European Commission; the Higher Regional Court of Düsseldorf; and the Court of Appeals, Conseil d’Etat, Conseil constitutionnel, and Tribunal of Commerce of Paris.\n\nPrior to joining Analysis Group, Dr. Chapsal founded MAPP, a Paris- and Brussels-based economic consultancy, which was acquired by KPMG in 2018. Previously, he worked in a US competition economics consultancy. Dr. Chapsal regularly publishes articles on competition economics, on subjects ranging from the econometric analysis of cartels to geographic market delineation and exclusionary strategies. He is an affiliated professor at the Sciences Po Department of Economics and a member of the CESifo academic research network.\n\n)\n\nDr. Mordecai is an expert on forensic financial and economic analysis, financial engineering, and the valuation of fixed-income securities and structured products, including over-the-counter derivatives – in particular, fixed-income and credit derivatives. He also has expertise in complex insurance and reinsurance liabilities, M&A and successor liability analysis, operational risk, reliability and warranty-indemnity analysis, environmental liability, trade credit, and political risk, as well as asset liability and risk management models and practices. In addition, Dr. Mordecai has direct experience with cryptocurrency and digital asset technology infrastructure, including the technical review and evaluation activities of distributed ledger technology. Dr. Mordecai has advised on, and provided technical oversight for, pattern and practice investigations, internal regulatory investigations, insurance investigations for state regulators, and stress testing for global financial institutions. He has testified extensively at deposition, trial, arbitration, and international arbitration; been admitted as an expert in federal, state, and county courts; and been cited favorably in court decisions. Dr. Mordecai has served as an advisor on systemic risk issues to the Federal Reserve, the International Monetary Fund (IMF), the US Department of the Treasury, and the Commodity Futures Trading Commission (CFTC), and as an advisor on hedge fund valuation issues to the International Organization of Securities Commissions. He has also been a member of the Investment Advisory Committee of the New York Mercantile Exchange (NYMEX). In addition to his role at The University of Chicago Booth School of Business, Dr. Mordecai is a visiting scholar at the NYU Courant Institute of Mathematical Sciences, where he co-advises research activities at the RiskEcon® Lab for Decision Metrics. Dr. Mordecai also co-teaches a course at NYU Law School on quantitative methods in litigation with a focus on machine testimony and machine behavior. His contributions to this course as co-instructor include extensive direct experience with technical review, evaluation, and testing of AI and machine learning applications across diverse institutional contexts, as well as industry and market settings.\n\n)\n\nMs. Kindler is an economist with extensive experience in a variety of engagements, including intellectual property (IP) disputes, contract disputes, litigation matters related to securities and finance, false advertising allegations, and antitrust matters. She has testified numerous times in deposition, trial, and arbitration and assisted in all phases of the litigation process, including discovery, expert reports, deposition, and trial preparation. With respect to IP disputes, Ms. Kindler has evaluated damages in the context of allegations of patent infringement, trade secret misappropriation, trade dress infringement, and copyright infringement. In patent infringement matters, she has analyzed claimed lost sales, claimed lost profits, and reasonable royalty damages. Ms. Kindler also has evaluated disgorgement and actual harm in the context of numerous IP disputes. Ms. Kindler has been involved in numerous licensing negotiations related to a wide range of technologies and products, including but not limited to standard essential technology, software, smartphone and wireless technologies, dental implants, and oil and gas. In antitrust matters, she has assessed the competitive consequences of mergers, analyzed the competitive behavior of market participants, and estimated the impact of market power. Her work has also included the development of complex damages models, the analysis of statistical data, and the analysis of stock price movements. Prior to joining Analysis Group, Ms. Kindler held positions with two economics consulting firms.\n\n)\n\nProfessor Tucker is an industrial organization economist whose research spans the fields of technology, health care, real estate, and media and advertising. A particular focus of her work is on the role of data and digitization on competition and consumer behavior. Professor Tucker has deep experience as an expert witness in a variety of cases spanning antitrust and competition, intellectual property, data and data privacy, online advertising, and digital platforms. She has assessed market definition, competitive effects, liability, and class certification issues in matters involving pharmaceuticals, health insurance, consumer goods, sports and entertainment, energy, and consumer electronics, among other industries. She has testified about the effects of data, privacy, and algorithms before Congress, and has presented her work to agencies and organizations such as the Federal Trade Commission (FTC), the Federal Communications Commission (FCC), the International Monetary Fund (IMF), the European Commission Directorate-General for Competition (DG COMP), and the Australian Competition and Consumer Commission (ACCC).\n\nProfessor Tucker has published widely on innovation and technology diffusion; online advertising, customer heterogeneity, and algorithms; privacy regulation; network effects; and the economics of social networks. At the National Bureau of Economic Research (NBER), she serves as a research associate, focusing on privacy; a principal investigator on the Project on the Economics of Digitization; and a co-organizer of the Economics of Artificial Intelligence initiative, supported by the Alfred P. Sloan Foundation. Professor Tucker is a co-founder of the MIT Cryptoeconomics Lab, which studies digital currencies and blockchain, and chair of the MIT Sloan Ph.D. Program. Her articles have appeared in leading scientific, economic, management, and marketing journals. She has previously served as associate editor of Management Science and the Journal of Marketing Research and coeditor of Quantitative Marketing and Economics, and she is currently senior editor of Marketing Science.\n\n)\n\nMr. McLean specializes in applying finance and economics to problems in complex business litigation, including securities, valuation, tax, and intellectual property (IP) matters. His experience spans several industries, from banking, insurance, and high tech to telecommunications and health care. He has served as an expert witness, and has provided assistance in many phases of litigation, including development, presentation, and review of pretrial discovery; preparation of testimony; and critique of analyses of opposing experts.\n\nMr. McLean’s case work has included general damages analyses, lost profit and reasonable royalty calculations related to IP misappropriation, and assessments of fiduciary duties and investment management. In addition, he has evaluated the economic characteristics and risk transfer of a range of financial instruments, such as private mortgage insurance, subprime loans, and preferred equity in a new venture. He has led large case teams in a number of high-profile matters, including consulting to the US Department of Justice (DOJ) regarding the financial issues involved in tribal trust fund disputes, and supporting counsel for a large electronics manufacturer in litigation associated with features on smartphones and tablets.\n\nIn addition, Mr. McLean has presented on topics related to damages assessment and patents. He has also worked with entrepreneurial companies, helping to develop financial projections, business plans, and marketing strategies.\n\n)\n\nProfessor Eden is an expert on transfer pricing and multinational enterprises (MNEs), with decades of experience consulting to MNEs, governments, and international organizations on transfer pricing and MNE strategies and structures. In transfer pricing matters, she has served as an expert witness – in cases that include Coca-Cola Co. v. Commissioner and In re: Nortel Networks – and filed numerous expert reports. Professor Eden has taught courses on transfer pricing, MNEs, and the economics of international business, and founded the Transfer Pricing Aggies program at Texas A&M University, which has trained hundreds of graduate students. She has extensive research experience in areas such as transfer pricing and MNE strategies in the digital economy, and her work has been widely published in management and international business journals. Professor Eden has authored several books, including Taxing Multinationals: Transfer Pricing and Corporate Income Taxation in North America, Multinationals in North America, The Economics of Transfer Pricing, and Research Methods in International Business. She is a frequent speaker at transfer pricing and tax conferences, as well as dean of the Fellows of the Academy of International Business, where she formerly served as president.\n\n)\n\nProfessor Weber is a deeply experienced technologist whose multidisciplinary research has focused on innovation in technology markets, intellectual property regimes, and the related behaviors of people, firms, and governments. His research, teaching, and advisory work centers on both private and public sector issues around information technology, software, cybersecurity, privacy, algorithms, and health care. Professor Weber has advised global technology companies, government agencies, and nonprofit organizations on strategy and risk analysis, using a diverse set of qualitative and quantitative methods fit to purpose. In litigation, Professor Weber has been retained on behalf of technology companies to analyze aspects of technological integration, including those involving data security and algorithms. He was the founder and faculty director for the UC Berkeley Center for Long-Term Cybersecurity, and his cybersecurity credentials enable him to supplement his experience in organizational governance issues with an understanding of the technical nature of security threats and responses. Professor Weber served as a special consultant to the president of the European Bank for Reconstruction and Development, and has held academic fellowships with the Council on Foreign Relations and the Center for Advanced Study in the Behavioral Sciences. He is a widely published author, whose books include The Success of Open Source and Bloc by Bloc: How to Build a Global Enterprise for the New Regional Order, which explains how economic geography is increasingly defined by technology rules and standards.\n\n)\n\nProfessor Tufano’s work spans a broad range of topics in finance, including climate finance and derivatives and structured finance. His research interests include financial innovation, business solutions to climate change, the design of new securities and financial instruments, the organization of financial markets, corporate risk management, the mutual fund industry, and household finance. Professor Tufano has provided expert testimony and reports in several finance- and securities-related matters, including a matter involving retained asset accounts; the Parmalat securities litigation; economic characterizations of securities for tax courts; and the Enron Corporation securities, derivative, and ERISA litigations.\n\nHe has written a number of books, and his articles have been published in journals such as The Journal of Finance, the Journal of Financial Economics, The Review of Financial Studies, and Harvard Business Review. He is an associate editor of the Journal of Investment Management. Professor Tufano’s work has also been featured in a number of media outlets, including The New York Times and the Financial Times. He has received several awards, including the Smith Breeden Prize for the best finance paper published in The Journal of Finance and a leadership award from the Aspen Institute. Prior to re-joining the Harvard Business School faculty, he was dean of the Saïd Business School at the University of Oxford for a decade.\n\n)\n\nMs. Kirk Fair has extensive experience leading the development of economic and market analyses, assessing class certification and damages, evaluating consumer behavior, and testifying in a wide range of matters in the US, Canada, and Europe. She has been deeply involved in merger investigations and major antitrust litigation, as well as intellectual property (IP), false advertising, and tax matters. She also is a founder of the Analysis Group’s Surveys & Experimental Studies practice.\n\nMs. Kirk Fair specializes in evaluating competition and substitution patterns to examine potential competitive effects in mergers and “but-for” outcomes in antitrust litigation. She has significant analytical and testifying experience in cartel matters, notably in a number of prominent cases in the technology, consumer products, and financial services industries. She also has evaluated competition, pricing, and outputs in connection with merger investigations in the US, Canada, and the EU. In addition to having served as a compliance monitor for several years, she has supported the US Department of Justice (DOJ), the Federal Trade Commission (FTC), and the Canadian Competition Bureau (CCB) in a variety of merger investigations.\n\nMs. Kirk Fair also has particular expertise in the development, administration, and analysis of consumer surveys for use in antitrust, false advertising, and IP matters, as well as merger reviews and strategy cases. She has testified in arbitration, deposition, and trial in matters involving the design and implementation of consumer surveys, as well as the evaluation of opposing parties’ surveys and of statistical sampling and analyses. Her work has been used to support and critique damages models and to provide insights into the role of consumer choice in market definition.\n\nMs. Kirk Fair serves as a Vice-Chair to the American Bar Association (ABA) Antitrust Law Section’s Pricing Conduct Committee. She has received numerous awards for her accomplishments, including the W@ “40 in Their 40s: Notable Women Competition Professionals” and the Concurrences Antitrust Writing Award for her coauthored article “The Tyranny of Market Shares: Incorporating Survey-Based Evidence into Merger Analysis” (Corporate Disputes).\n\nRead Rebecca's profile\n\n)\n\nMr. Giles is a financial economist focusing on valuation and financial analysis. He has worked extensively in international arbitration, including both commercial and investment treaty claims, and has been engaged in some of the most complex and high-profile financial and non-financial disputes. His experience covers a range of industries across the world, including financial services, energy, pharmaceuticals, software, luxury goods, mining, manufacturing, property development, and hotels. Mr. Giles has testified as a quantum expert in all the major international arbitration forums and in a number of High Court of Justice cases in London. In Galapagos Bidco S.À.R.L. v. Dr. Frank Kebekus, et al., a contentious financial restructuring, he was instructed by counsel for Galapagos Bidco S.À.R.L. Mr. Giles has also assessed the impact of restated accounts on the value of Autonomy in HP/Autonomy v. Lynch and Hussain; other restructurings, including Saltri III Ltd v. MD Mezzanine SA SICAR; and the challenge to the $50 billion Yukos award in the Netherlands.\n\n)\n\nProfessor Morrison is an expert in bankruptcy law and economics, including the causes and consequences of both corporate and consumer insolvency. In his current work, he studies patterns in inter-creditor agreements, valuation disputes in corporate bankruptcies, racial disparities in Chapter 13 bankruptcy filings, the relationship between financial distress and mortality rates, and the costs and benefits of the bankruptcy code’s special rules for financial contracts, such as repurchase agreements.\n\nProfessor Morrison teaches courses in corporate finance, bankruptcy law, and contracts, and was the recipient of Columbia Law School’s 2018 Willis L.M. Reese Prize for Excellence in Teaching. He has published widely on corporate reorganization, consumer bankruptcy, regulation of systemic market risk, and foreclosure and mortgage modification. His work has been cited by the bankruptcy bench and bar, and has received support from the National Science Foundation and The Pew Charitable Trusts. He was a co-recipient of the John Wesley Steen Law Review Writing Prize from the American Bankruptcy Institute for his research on the Dodd-Frank Act.\n\nProfessor Morrison has served as a director of the American Law and Economics Association and as a member of the US Supreme Court’s Advisory Committee on Bankruptcy Rules. He is a former associate editor of the American Law and Economics Review and is currently an editor of The Journal of Legal Studies. Prior to his academic appointments, Professor Morrison clerked for Justice Antonin Scalia and Judge Richard A. Posner.\n\n)\n\nProfessor Wei is the scientific director for the program of quantitative science in pharmaceutical medicine at the Harvard T.H. Chan School of Public Health. He is an expert in biostatistics and in the development of statistical methods for the design and analysis of clinical trials, and has provided deposition and trial testimony in numerous matters regarding the effectiveness of various therapies. Professor Wei also has served as an expert and advisor to a number of pharmaceutical companies and regulatory agencies, including the US Food and Drug Administration (FDA), and has served on a number of FDA and National Institutes of Health committees.\n\nProfessor Wei has developed numerous statistical methods that are utilized extensively in practice. He has concentrated his recent research on the development of personalized medicine strategies for diagnostics and treatment selection, and has been intimately involved in advising the pharmaceutical industry on new drug applications.\n\nThe author of more than 140 articles in statistical and medical journals, Professor Wei has served on the editorial boards of the Journal of the American Statistical Association and the Journal of Biopharmaceutical Statistics. He is an elected fellow of the Institute of Mathematical Statistics and the American Statistical Association, which honored him with the Mosteller Statistician of the Year award in 2007.\n\n)\n\nFor more than 25 years, Mr. Christensen has worked on high-stakes litigation matters with world-class experts, supporting their testimony at both bench and jury trials. His work has focused on valuation and appraisal matters, private equity disputes, antitrust and consent decree litigations, bankruptcy, and tax and transfer pricing dispute resolutions. Through his extensive experience, he has developed a deep understanding of the high-tech, digital advertising, pharmaceutical, media and entertainment, and finance industries. In addition to his litigation work, Mr. Christensen has also assisted in the preparation of numerous impact studies in the high-tech space on issues such as cloud computing and storage, broadband availability, virtual and augmented reality, artificial intelligence, and the metaverse. His clients have included Meta/Facebook, Google, GSK, AstraZeneca, JAB Holding Company, Bank of America, BNP, and Fidelity. Among his engagements are high-tech antitrust matters, a GSK transfer pricing dispute, the Nortel Networks bankruptcy, Delaware appraisal trial victories involving PetSmart and Panera, and rate-setting trials for BMI. Mr. Christensen is a CFA charterholder.\n\n)\n\nDr. Mortimer specializes in health economics, industrial organization, microeconomic theory, and econometrics. He has extensive experience with issues involving competition, intellectual property, marketing, pricing, and valuation with a focus on the health care industry. He has evaluated questions of class certification, damages, liability, and market definition in antitrust matters. He also has provided economic analyses and expert testimony on causation, damages, and valuation in a variety of health care cases, including cases involving allegations of False Claims Act (FCA), Anti-Kickback Statute (AKS), and Lanham Act violations. In addition to his work in litigation, Dr. Mortimer has assisted pharmaceutical and medical device manufacturers on pricing and contracting issues and authored several public policy studies related to legislation establishing a biosimilar approval pathway, biosimilar competition, pharmaceutical pricing, generic drug competition and the role of authorized generic entry, and paragraph IV abbreviated new drug application (ANDA) filings. His research has been published in leading peer-reviewed journals, including Health Affairs, Nature Reviews Drug Discovery, The Journal of Industrial Economics, and the Journal of Medical Economics.\n\n)\n\nArnold Barnett's research specialty is applied mathematical modeling generally focused on problems of health and safety. His early work on homicide was presented to President Ford at the White House, and his analysis of US casualties in Vietnam was, among other things, the subject of a column by William F. Buckley. He has received the President's Award and the Expository Writing Award from INFORMS (1996 and 2001, respectively) and the President's Citation from the Flight Safety Foundation (2002) for “truly outstanding contributions on behalf of safety.” He has written op-ed pieces for The New York Times, The Wall Street Journal, The Boston Globe, and USA Today. Ten times he has been honored for outstanding teaching by students at MIT's Sloan School of Management; in 1992, Business Week described him as the “best” Sloan School faculty member. Dr. Barnett has testified in many legal proceedings as a statistical expert and an aviation-safety expert.\n\n)\n\nMr. Gissiner has more than four decades of diversified experience in the retirement plan industry. He is an expert in retirement plan design, compliance, administrative procedures, employee communications and investment education services, and fiduciary responsibility and oversight. Mr. Gissiner has consulted on these and other topics to hundreds of retirement plan sponsors over the course of his career, including various Fortune 500 companies, mutual fund and insurance companies, banks, health care providers, and institutions of higher learning. In addition, he has served as an expert witness in various litigation matters involving defined-contribution retirement plans.\n\nAt Orchard Hills Consulting, Mr. Gissiner currently consults on behalf of a number of clients on a wide range of retirement plain issues including (but not limited to) retirement plan administration and compliance consulting, fee benchmarking, assisting plan sponsors and committees in understanding and implementing administrative and recordkeeping fee arrangements, developing service provider requests for proposals, and reviewing modifications to existing plan features and provisions. Earlier in his career, he was a partner in the benefits consulting practice of Coopers & Lybrand. Later, he served as the West Region Managing Partner for retirement plan administrative outsourcing services at PriceWaterhouseCoopers.\n\n)\n\nDr. Lehmann specializes in applying microeconomics, econometrics, and statistical methods to complex litigation and government investigations in the areas of antitrust and competition, labor and employment, health care, and commercial damages. She has evaluated market definition, market power, competitive dynamics, class certification, liability, and damages issues in cases involving allegations of price-fixing, monopolization, and other anticompetitive conduct. Dr. Lehmann has extensive experience in labor market antitrust matters involving allegations of no-poach and wage-fixing agreements in a variety of industries. In her work with pharmaceutical and medical device industries, she has analyzed economic, health, and scientific data to assess liability, damages, and claims of causation and harm. She also frequently supports biostatisticians, epidemiologists, scientists, and regulatory experts in evaluating research and development processes and analyzing clinical trial, laboratory testing, registry, medical claims, and adverse events data in product liability litigations and intellectual property disputes. She has authored expert reports and provided testimony in competition, data security breach, labor and employment, and commercial litigation matters.\n\nDr. Lehmann’s research has been published in the Journal of Economic Literature, The Journal of Human Resources, Labour Economics, Cartel & Joint Conduct Review, Distribution, Cybersecurity Law & Strategy, and Antitrust Report, and her academic work has been cited in leading media outlets, including Scientific American, Forbes, and BBC News. She serves as a co-chair of the Distribution and Franchising Committee of the American Bar Association (ABA) Antitrust Law Section. Prior to joining Analysis Group, Dr. Lehmann was an assistant professor of economics at the University of Houston, where she taught courses in labor economics and microeconomics.\n\n)\n\nDr. Cliff is a financial economist with expertise in a range of topics, including asset valuation, mergers and acquisitions (M&A), tax shelters, stock analysts’ recommendations, IPOs, REITs, derivatives, and hedge funds. He has extensive experience with large financial datasets, sophisticated econometric models, and simulations. In his consulting engagements, Dr. Cliff has addressed damages modeling, class certification, business and asset valuation, analysis of complex financial structures, analysis of solvency and debt covenants, evaluation of investment strategies, and assessment of due diligence practices. In these assignments, he has managed large case teams, designed and performed analyses in support of expert reports, critiqued opposing expert reports, and assisted with preparation for depositions and trial. Dr. Cliff has also served as an expert on cases involving valuation, damages, and liquidity discounts. Prior to joining Analysis Group, Dr. Cliff was a finance professor for nine years at Purdue University and Virginia Tech, where he taught a variety of courses at the undergraduate, M.B.A., and Ph.D. levels. His academic research has been published in leading journals such as the Journal of Finance, the Journal of Business, and Financial Management.\n\n)\n\nMs. Glowka is a chartered accountant who specializes in the assessment of damages and forensic analysis arising in the context of dispute resolution. She has served as an expert and led consulting teams on complex UK and international assignments, including litigation and international arbitration matters in all the major international arbitration forums, as well as before the High Court of Justice in London, the Scottish Court of Session, and the UK Competition Appeal Tribunal.\n\nMs. Glowka has acted on a broad range of litigation and arbitration matters across the automotive, oil and gas, pharmaceutical, telecommunications, software, and consumer products industries, among others. Her litigation and arbitration work has involved the evaluation of damages arising in the context of contractual and shareholder disputes, as well as post-transaction disputes such as breach of warranty claims. Ms. Glowka’s forensic accounting work has spanned the analysis and tracing of funds and transactions, as well as the evaluation of fraud and accounting irregularities, including allegations of accounts manipulation for inflating performance-related bonuses and purchase consideration. She has also evaluated complex financial reporting issues under a variety of accounting standard-setting regimes, including UK generally accepted accounting principles (GAAP) and International Financial Reporting Standards (IFRS). Ms. Glowka is a member of Chartered Accountants Australia and New Zealand.\n\n)\n\nProfessor Wermers is an expert on the hedge fund, pension fund, and mutual fund industries. His research interests include investment fund performance measurement, the impact of mutual funds on stock markets, closed-end funds, empirical tests of the efficiency of stock markets, and the role of institutional investors in setting security prices. Professor Wermers’s research has created new methods of measuring and attributing the performance of investment fund managers. His work also addresses whether investment managers who actively manage portfolios can consistently outperform passively managed funds. Professor Wermers has served as an expert witness in numerous matters, including challenges to mutual fund fees (Sivolella v. AXA Equitable Life Insurance Company) and ERISA class action cases challenging the selection and retention of investment funds for defined-contribution plans (Pledger v. Reliance Trust Company, Ramos v. Banner Health, and Baird v. BlackRock Institutional Trust Company). In Ramos, the judge credited his testimony with supporting the reasonableness of the Fidelity Freedom funds. He has also consulted to asset management companies and US government agencies. Professor Wermers was appointed to and serves as a member of the US Securities and Exchange Commission’s Asset Management Advisory Committee, which was formed in 2019. He is coauthor of Performance Evaluation and Attribution of Security Portfolios, a scientific textbook on measuring portfolio manager performance.\n\n)\n\nProfessor Chevalier is an expert in industrial organization, finance, and competitive business strategy. She has provided expert testimony and been deposed in several major antitrust matters, including State of New York v. Intel Corporation, in which she assessed the business strategies of competitors in the semiconductor industry and evaluated market outcomes. An affiliate with Analysis Group, Professor Chevalier, supported by Analysis Group teams, recently served as an expert in litigation involving online search databases, and in several matters involving entertainment industry issues related to rights, prices, and competition. She has also assisted a number of major technology firms with analyses of competition and antitrust issues. Professor Chevalier's academic research focuses on the economics of electronic commerce, the interaction between firm capital structure and product market competition, and price seasonality and cyclicality. Her research has been featured in Slate magazine and on National Public Radio. Professor Chevalier is also an elected member of the American Academy of Arts and Sciences. She is a former member of the American Economic Association's (AEA) Executive Committee and a former board member of the organization's Committee on the Status of Women in the Economics Profession. In 1999, she won the first biennial Elaine Bennett prize, given by the AEA in recognition of research by a woman in any area of economics. Professor Chevalier is an active author. She has published articles in the American Economic Review; Journal of Industrial Economics; Journal of Business; Quarterly Journal of Economics; Journal of Finance; Journal of Law, Economics, and Organization; and Journal of Political Economy. She is a former coeditor of the Rand Journal of Economics and has served as a coeditor of the American Economic Review, editor of the B.E. Journal of Economic and Policy Analysis, advisory editor of Quantitative Marketing and Economics, and associate editor of numerous journals.\n\n)\n\nDr. Rice is an economist with a range of expertise in health economics, industrial organization, finance, statistics, and econometrics. He has extensive experience applying economic theory and statistical methods in complex litigation and research settings. Dr. Rice has led analyses related to government investigations and litigation matters, where he has supported counsel and served as an expert on alleged False Claims Act (FCA) violations, as well as on antitrust, cryptocurrency, insider trading, misappropriation of trade secrets, and breach of contract issues. In matters related to liability and damages, he conducts empirical analyses involving large-scale databases on a range of topics, including causal inference, merger simulation, and lost profits and budget impact. Dr. Rice’s case experience has involved assisting in the preparation of expert reports, testimony, and rebuttal analyses and arguments; developing sophisticated interactive models enabling real-time damages assessments under alternative scenarios; and presenting analyses to US Attorney’s Office investigators. In addition to his litigation work, he has provided econometric and statistical consulting on matters such as risk management, fair market valuation, and compliance. Dr. Rice is an adjunct faculty member of the Harvard University Department of Economics and has taught undergraduate courses on econometrics, health economics, industrial organization, and regulatory economics. He has published extensively in numerous peer-reviewed journals, and presented at conferences and seminars.\n\n)\n\nProfessor Haas-Wilson is an expert in health care antitrust, including the competitive effects of hospital mergers and commercial health insurer mergers, the effects of vertical consolidation in health care markets, and the implications of physician networks on competition in the health care industry. She recently testified in Federal District Court in Idaho on behalf of plaintiffs, in an antitrust lawsuit alleging competitive harm from St. Luke’s Health System’s acquisition of a large independent physician practice. She has served as a consultant on antitrust issues to the Federal Trade Commission, the Massachusetts Attorney General, the California Department of Corporations, and numerous private entities. She also testified on behalf of the Federal Trade Commission in the matter of Evanston Northwestern Healthcare Corporation. Professor Haas-Wilson is the author of Managed Care and Monopoly Power: The Antitrust Challenge and coeditor of Uncertain Times: Kenneth Arrow and the Changing Economics of Health Care. Her research has appeared in the Journal of Political Economy, the Journal of Economic Perspectives, the Journal of Law and Economics, the Review of Economics and Statistics, and the Journal of Health Economics, among others.\n\n)\n\nProfessor Golder's research focuses on innovation, branding, and global marketing strategy. His research on market entry timing, new products, long-term market leadership, and quality has received widespread acclaim, including the William F. O'Dell Award (Journal of Marketing Research); the Harold H. Maynard Award (Journal of Marketing); the INFORMS Long Term Impact Award (Marketing Science); the Frank M. Bass Award (Marketing Science); the Berry Book Prize (American Marketing Association); and recognition from the Harvard Business Review for co-authoring one of the Top Ten Business Books of the Year (2002). His recent research includes an examination of how economic conditions affect long-term brand leadership persistence and how consumers learn to use multi-feature products like smartphones and websites. He has also recently developed an integrated framework of quality encompassing produced quality, experienced quality, evaluated quality, customer expectations, and customer satisfaction; and explored the historical origins of radical innovations including how they are developed and commercialized.\n\nPrior to joining Tuck, he was Professor of Marketing, George and Edythe Heyman Faculty Fellow, and marketing department doctoral program coordinator at New York University's Stern School of Business. He has also held one-year faculty appointments at UCLA and Peking University's Guanghua School of Management. Professor Golder has six years of professional experience in the aerospace and oil industries and has consulted in other industries. He is the co-Editor-in-Chief of Marketing Letters, sits on the editorial review boards of other leading academic journals and is a long-time advisor and speaker to industry audiences and corporate executives. He holds a Ph.D. in Business Administration (Marketing) from the University of Southern California, and a B.S. in Mechanical Engineering from the University of Pennsylvania.\n\n)\n\nDr. Navathe is a health economist and practicing physician who specializes in payment model design and evaluation and applications of statistical and machine learning to clinical decision making. His research focuses on the impact of value-based care and payment models on health care value; financial and nonfinancial incentive design for clinician practices; and the intersection of clinical trials and observational data analyses. Dr. Navathe is a staff physician at the Corporal Michael J. Crescenz Veterans Affairs Medical Center and vice chair and commission member of the Medicare Payment Advisory Commission, a nonpartisan agency that advises the US Congress on Medicare policy. He has served as a fellow on the President’s Council of Economic Advisers and as a medical officer and senior program manager of a US Department of Health and Human Services program on the comparative effectiveness of patient-centered outcomes research. He is also the cofounder of Embedded Healthcare (now Clarify Health), a company that applies behavioral economics to the development and adoption of value-based care model design in clinical practices. Dr. Navathe has published his research in numerous peer-reviewed journals and is the founding coeditor in chief of HealthCare: The Journal of Delivery Science and Innovation. His research has been funded by the National Institutes of Health, the Robert Wood Johnson Foundation, and The Commonwealth Fund, among others. Dr. Navathe is a recipient of Johns Hopkins University’s Daniel E. Ford Award for achievement in health services and outcomes research.\n\n)\n\nMr. Cohen has over 30 years’ experience as an expert in international arbitration, valuation, antitrust, intellectual property, and securities, and has testified in arbitration and federal courts on many aspects of economic damages. He specializes in fields that are intensive in intangible assets such as patents, copyrights, trademarks, and trade secrets. He has worked across a wide range of industries, including health care, software and technology, financial services, energy, transportation, and entertainment.\n\nMr. Cohen has worked with significant corporations including Apple, Microsoft, Oracle, Wells Fargo, State Street, Wachovia, SoundExchange, ASCAP, Liberty Mutual, Allstate Insurance, Johnson & Johnson, AstraZeneca, Astellas, United Airlines, TWA, DaimlerChrysler, Mitsubishi, and Anheuser-Busch. He also has experience in matters related to the US Federal Trade Commission, the US International Trade Commission, the Tax and Antitrust Divisions of the US Department of Justice, the Republic of Uruguay, and the Commonwealth of Australia.\n\nMr. Cohen is the author of Intangible Assets: Valuation and Economic Benefit and a contributor to the American Bar Association publication Proving Antitrust Damages. He has been a guest lecturer at both Northwestern University and The University of Chicago. He is also a prolific songwriter.\n\n)\n\nProfessor Wilks is an expert in accounting and financial reporting – specifically, the application of both US generally accepted accounting principles (GAAP) and International Financial Reporting Standards (IFRS) to revenue recognition transactions, consolidation of variable interest entities, leases, transfers of financial assets, and fair value measurement. His research examines financial reporting policies, revenue recognition, the auditing of fair value measurements, and fraud detection. From 2006 to 2009, Professor Wilks was an academic fellow at the Financial Accounting Standards Board (FASB) and a technical consultant to the International Accounting Standards Board (IASB). During this time, he managed the Revenue Recognition Project, coauthored over 50 research memos, and led board deliberations on these memos. Professor Wilks has served as a technical advisor to Connor Group, which provides GAAP review and Securities and Exchange Commission (SEC) reporting guidance to firms preparing for IPOs. He has also consulted to the SEC and various public companies. His extensive research on accounting-related topics has been published in The Accounting Review, the Review of Accounting Studies, Contemporary Accounting Research, Auditing: A Journal of Practice & Theory, and Management Science. Professor Wilks is the founder and faculty advisor of RevenueHub, which has published more than 90 articles on Accounting Standards Codification (ASC) Topic 606, revenue recognition.\n\n)\n\nPierre Cremieux, President of Analysis Group, has a broad range of expertise in health economics, antitrust, statistics, and labor economics. He has consulted to numerous clients in the US and Canada and testified in bench and jury trials, arbitrations, and administrative proceedings.\n\nDr. Cremieux has served as an expert and supported other experts in both litigation and non-litigation matters on antitrust issues; general commercial claims; contractual disputes; and a number of labor-related matters in a variety of industries, including high tech, pharmaceuticals, biotech, financial products, consumer products, and commodities. He has assessed the evaluation of damages on a class-wide basis in some of the largest class action matters in recent years.\n\nHis scientific research in antitrust economics, class certification, health economics, and statistics has been published in numerous peer-reviewed journals including the George Mason Law Review, the American Bar Association Economics Committee Newsletter, The Review of Economics and Statistics, the Journal of Health Economics, Industrial and Labor Relations Review, the Journal of Clinical Oncology, and the American Journal of Managed Care. Dr. Cremieux's research has been cited in leading media outlets including The Wall Street Journal and Forbes.\n\nDr. Cremieux has frequently presented at leading legal, health care, and economics seminars on topics such as antitrust, class certification, health economics, and statistics, in both the United States and Canada. He has also been invited to teach courses on economics, statistics, health care, and antitrust at various schools including McGill University, Boston University, Harvard Medical School, and Yale's School of Management.\n\nPrior to joining Analysis Group in 1997, Dr. Cremieux spent five years as a professor at the University du Québec à Montréal, and served as an adjunct professor from 1997 to 2018.\n\n)\n\nMs. Hitscherich specializes in corporate acquisitions, leveraged buyouts, exclusive sales and divestitures, takeover defenses, and restructurings. She has served as an expert witness in several complex securities litigations, including matters involving deal structure, valuation, due diligence, custom and usage in the finance industry, and financing alternatives.\n\nMs. Hitscherich has extensive experience in investment banking and corporate law practice, including as a managing director in mergers and acquisitions with Banc of America Securities, where she was secretary of the Fairness Opinion Review Committee; vice president in mergers and acquisitions with J.P. Morgan & Co., where she was a founding member of the takeover defense team and a senior member of the acquisitions fairness Advisory Review Committee; and as a mergers and acquisitions attorney with Skadden, Arps, Slate, Meagher & Flom.\n\nAt Columbia Business School, Ms. Hitscherich teaches corporate finance, advanced corporate finance, business law, and mergers and acquisitions in the M.B.A. and Executive M.B.A. programs.)\n\nDr. Rothman specializes in the economic analysis of antitrust and competition issues. He has supported economic experts on multiple merger matters on behalf of the US Department of Justice (DOJ), the US Federal Trade Commission (FTC), and merging parties. He has also been retained by multiple private parties to present analyses to the DOJ and FTC and has testified for the DOJ and FTC as an expert witness in merger litigation. In addition to his merger work, Dr. Rothman has worked on multiple joint conduct and unilateral conduct matters.\n\nDr. Rothman is a senior editor of the Antitrust Law Journal. He has published research in outlets including Antitrust Law Journal, The Antitrust Source, Journal of Health Economics, Journal of Competition Law & Economics, and Concurrences: Competition Law Journal. Dr. Rothman has taught a course on the economics of merger analysis in the economics department at Harvard University. Prior to joining Analysis Group, he was an assistant professor at Columbia University.\n\n)\n\nProfessor Dranove's research focuses on problems in industrial organization and business strategy, with an emphasis on the health care industry. He has published nearly 100 research articles and book chapters, and is the author of six books, including The Economic Evolution of American Healthcare, Code Red, and the textbook The Economics of Strategy, which is used by leading business schools around the world. Professor Dranove regularly consults with leading health care organizations in the public and private sectors. He also has two decades of experience performing and testifying about economic analyses in both litigation and regulatory actions. Most recently, he testified on competition issues for the US Department of Justice in the agency's effort to block a proposed merger of two commercial health insurers. Professor Dranove concluded that the proposed transaction likely would result in higher prices and less innovation. He also has served on the executive committee and board of directors of the Health Care Cost Institute. Professor Dranove is on the review board of numerous prominent industry journals; he is the editor of the International Journal of Health Economics and Management and an associate editor of the RAND Journal of Economics.\n\n)\n\nMr. Willett has over 25 years of experience in financial and executive management. He is the former chief operating officer of Merrill Lynch Europe, Middle East & Africa, responsible for the firm's business activities in the region, including private client, institutional investor, investment banking, securities trading, and asset management. Prior to that, he served as senior vice president and chief financial officer of Merrill Lynch & Co., Inc., responsible for the company's audit, controller, tax, credit, investor relations, and treasury functions. Prior to joining Merrill Lynch, Mr. Willett served six years with Chase Manhattan Bank, where he was vice president in the Chase financial policy division. Since 2002, he has served as a director of the Marsico Investment Fund and chair of its audit committee.\n\n)\n\nDr. Good, an expert on user experience research and user behavior concerning technology, security, and privacy, has over 15 years of experience as a research scientist and technologist. He has co-developed technologies and designs for privacy protection products that have grown to millions of users, and he has worked with Fortune 100 firms to develop privacy and security solutions. Dr. Good has consulted on a variety of consumer protection cases, as well as civil and criminal investigations; provided testimony on his research before Congress and the Federal Trade Commission (FTC); and presented before the FTC on consumer protection and competition issues. He has been a consulting and testifying expert for the California Department of Justice and the FTC on notice design for mobile and web applications, the re-creation and testing of consumer experiences on such applications, and network and technical analysis related to privacy and security investigations. Dr. Good has published extensively on user experience studies, privacy, and security-related topics. His work has been covered by The Economist, The New York Times, the San Francisco Chronicle, ABC, and CNN. Dr. Good holds multiple software technology patents related to multimedia systems, event analysis, and information extraction. His prior experience includes research positions with PARC, Yahoo!, and HP Research Labs. In addition to his positions at the University of California, Berkeley, and Good Research, he is the CEO of AppCensus, a data privacy analysis firm focused on mobile devices.\n\n)\n\nMs. Mulhern specializes in the application of economic principles to issues arising in complex business litigation. She has served as an expert witness on damages issues in commercial litigation matters, including intellectual property (IP) and breach of contract cases, providing testimony in various district and state courts. Ms. Mulhern’s intellectual property damages experience includes cases involving allegations of patent, copyright, and trademark infringement, as well as misappropriation of trade secrets; she has also provided expert testimony on these issues in Section 337 cases at the International Trade Commission (ITC). Before the ITC, she has testified on a variety of economic issues, such as domestic industry, remedy, bonding, commercial success, and public interest. Ms. Mulhern’s litigation experience spans a variety of industries, including pharmaceuticals, medical devices, automotive, entertainment, consumer products, computer hardware and software, semiconductors, and telecommunications. In non-litigation matters, she has assisted clients in valuing intellectual property and other business assets in the context of strategic alliances and joint ventures. Ms. Mulhern has been recognized as among the top economic experts for IP matters by Intellectual Asset Management (IAM) in the IAM Patent 1000, which identifies leading patent professionals around the globe. She is a member of the American Economic Association and the Licensing Executives Society, and is a frequent writer and speaker on issues related to intellectual property valuation and damages assessment.\n\n)\n\nProfessor Hart is a leading expert in contract theory, the theory of the firm, and corporate finance. In 2016, he and Professor Bengt Holmström were awarded the Nobel Prize in Economics for their work in contract theory. Professor Hart’s research centers on the roles that ownership structure and contractual arrangements play in the governance and boundaries of corporations. His recent work involves determining how parties can write better contracts, as well as how a new model of corporate governance can better incorporate the importance shareholders place on nonfinancial criteria.\n\nProfessor Hart has consulted to businesses and government entities, and provided expert testimony on contract and governance disputes in which he has evaluated the business purpose and economic substance of special purpose entities. As an expert on behalf of Qualcomm in Apple v. Qualcomm, he provided guidance on the optimal structure of contracts, and why and when they should be enforced. His book Firms, Contracts, and Financial Structure is a leading work in the fields of contract theory and corporate finance. He has published widely in peer-reviewed journals and contributed to the Financial Times and The Wall Street Journal. Professor Hart is a member of the IGM (Initiative on Global Markets) Economics Experts Panel of The University of Chicago Booth School of Business, and is affiliated with the Program on Corporate Governance at Harvard Law School’s John M. Olin Center for Law, Economics, and Business. He is a past president of the American Law and Economics Association.\n\n)\n\nProfessor Goodstein's executive teaching and consulting are in the areas of customer focus, building and managing brand equity, strategic marketing management and positioning, integrated marketing communications, and consumer behavior. His work has been taught to some of the world's leading companies, including Prudential, Microsoft, Dow, CR Bard, Amoco, Shell Oil, HSBC, Credit Suisse, Lexis/Nexis, M&M Mars, Kimberly-Clark, Siemens AG, and many other Fortune 500 firms. Professor Goodstein has served as an expert witness in a number of trademark infringement, false advertising, and patent infringement matters. His experience includes testimony before the US Federal Trade Commission related to consumers' likelihood of confusion in response to online search advertising In the Matter of 1-800 Contacts, Inc., and congressional expert testimony before the House Committee on Veterans' Affairs (Oversight and Investigations Subcommittee) regarding media outreach to veterans. Professor Goodstein has consulted on social media strategy with firms such as Dell, Microsoft, Fleishman/Hillard, Baker MacKenzie, CR Bard, and IBM. He has written articles about the strengths and drawbacks of social marketing (e.g., Trademark Reporter, 2015) and his research on consumer behavior, building and managing brand equity, strategic marketing management and positioning, and integrated marketing communications has been published in prestigious journals, such as the Journal of Consumer Research, Journal of Marketing Research, Journal of Marketing, Journal of Public Policy & Marketing, and Pricing Strategy and Practice. Professor Goodstein serves on the editorial boards of the Journal of Consumer Psychology, the Journal of Retailing, Marketing Letters, and the Decision Sciences Journal. He is also on the board of advisors for the Institute for Brand Management. Professor Goodstein was previously awarded the American Marketing Association of Washington, DC's prestigious “Hall of Fame” award for his marketing teaching and practice in the metropolitan area.\n\n)\n\nProfessor Peress is an expert in finance, specializing in capital markets, asset pricing, and portfolio theory. His theoretical and empirical research focuses on the generation and diffusion of information in financial markets, with applications to asset management, financial disclosures, media, and economic growth. His experience as an expert in securities litigation includes consulting work and the preparation of expert reports.\n\nProfessor Peress has published numerous articles in leading academic journals, including The Journal of Finance, TheReview of Financial Studies, The Journal of Portfolio Management, and The Journal of Economic Theory. He was twice awarded the Smith Breeden Prize for best paper published in The Journal of Finance, and was recognized in 2011 as the “Best Young Researcher in Finance,” a title awarded by the Institut Louis-Bachelier and the Institut Europlace de Finance, two foundations that promote financial research. Professor Peress serves as coeditor of The Review of Finance, the leading academic finance journal in Europe. He also served as a visiting scholar at Princeton University's Bendheim Center for Finance in 2006, the London School of Economics in 2007–2008, and University of Southern California's Marshall School of Business in 2013–2014. An accomplished teacher, he was twice awarded the Deans' Commendation for Excellence in M.B.A. Teaching. While working on his Ph.D. in economics at the University of Chicago, Professor Peress worked at Lehman Brothers in both the fixed-income research and emerging market desk groups based in London and New York, respectively.\n\n)\n\nDr. Royer applies a broad range of quantitative tools to address client needs in data science, statistics, HEOR, finance, intellectual property, competition policy, and antitrust cases in the United States, Canada, and the EU. His recent work includes predicting the potential future onset of rare or undiagnosed conditions with machine learning models; predicting whether patents would be considered essential to technological standards if challenged in courts; valuing patents in the communications industry; evaluating damages related to product defects; analyzing investment guidelines in securities lending suits; addressing allegations of monopolization in major antitrust cases involving high tech firms; and supporting many academic experts on mutual fund market timing and excess fee cases. In addition, Dr. Royer has conducted extensive academic research and coauthored books and papers on topics such as using new AI advances in HEOR; predicting treatment resistance in tuberculosis, using machine learning algorithms in propensity score models; measuring the impact of ESO backdating on shareholders’ wealth; analyzing mutual fund pricing; analyzing antitrust limit pricing; valuing private investments for hospitals in Canada; determining the impact of hypertension therapies on mortality; and comparing unemployment compensation in different countries.\n\n)\n\nProfessor Hochberg specializes in entrepreneurship, innovation, venture capital, and private equity, focusing on venture capital networks, entrepreneurial finance, seed accelerators, and corporate governance and compensation. Her research covers topics such as venture capital investment performance, the effects of networks and syndication on venture capital firms, and investment selection. Professor Hochberg has also explored the private equity investment choices of pension funds and other institutional investors, as well as broad-based option compensation in firms. She is the managing director of the Seed Accelerator Rankings Project, which publishes annual rankings of accelerator programs in the US. Prior to joining the Rice faculty, she held positions at the Kellogg School of Management at Northwestern University and the Samuel Curtis Johnson Graduate School of Management at Cornell University. She has taught courses on entrepreneurial finance and health care innovation, and has served as an associate editor of several finance journals, including the Journal of Empirical Finance and the Journal of Banking and Finance. Professor Hochberg is a recipient of the Ewing Marion Kauffman Prize Medal for Distinguished Research in Entrepreneurship, and a research associate at the National Bureau of Economic Research. Prior to joining academia, she was a software engineer at both established and startup technology companies, and co-founded a startup. Professor Hochberg is an active angel investor and advisor to startups, and a Landmark Fellow with Landmark Partners, a large private equity investor in secondary markets. She is a co-founder of Flywheel Innovation, a corporate innovation advisory firm.\n\n)\n\nProfessor Wohlgenant specializes in the development of economic models related to agricultural marketing, innovation, policy, and price analysis, including farm-to-retail price linkages. He has had extensive commodity experience, including work on applied price and marketing problems for dairy, beef, pork, poultry, eggs, grapes, wine, sugar, tobacco, cotton, and horticultural crops. Professor Wohlgenant's research has been widely published in leading professional journals, and he has won best article awards in four journals, including the American Journal of Agricultural Economics. He is also the recipient of a Publication of Enduring Quality Award from the Agricultural & Applied Economics Association (AAEA), and he is a past editor of the American Journal of Agricultural Economics. For outstanding service to the profession of agricultural economics, he was elected a fellow of the AAEA in 2001.\n\nProfessor Wohlgenant has served as an expert witness in federal and state court and in regulatory proceedings, including a cattle import investigation before the US International Trade Commission. He has also served as an economic consultant for RTI International, the Food and Agriculture Organization of the United Nations, the US Department of Agriculture, and the US Government Accountability Office. He is signatory to three amicus curiae briefs submitted to the US Court of Appeals related to innovation incentives in the pharmaceutical industry.\n\n)\n\nMr. Darling consults to clients and provides expert testimony to address litigation, strategy, regulatory, and policy questions in a wide range of antitrust and competition, class certification, health care, energy, and environmental matters. He has submitted and supported expert testimony before US district and appellate courts, state utility commissions, siting boards, and federal agencies. He has also assisted clients with responses to government investigations and presented findings before US Attorneys’ Offices, state attorneys general, and the US Drug Enforcement Administration.\n\nIn the areas of health care and antitrust, Mr. Darling has extensive experience supporting clients on issues related to discovery and data production, class certification, patent infringement, market definition and market power, and competitive effects in pharmaceutical and life sciences matters involving patent infringement issues, reverse payment settlements, and product hop allegations. He has also designed and implemented customized suspicious order monitoring (SOM) and loss prevention programs for controlled substances, and has experience in False Claims Act and Anti-Kickback Statute litigation cases, including analyses of causation and damages calculations.\n\nMr. Darling is also an expert on electricity, oil, and natural gas pricing, markets, and infrastructure. His consulting work on behalf of utilities, state and regional organizations, and global companies includes projects related to cost/benefit analyses of new plant construction and retirements; ratepayer and bill impacts; environmental effects of emissions and pollution controls; economic impacts of energy projects, mergers, and policies; natural gas, biomass, and other market studies; and climate change matters including decarbonization policy proposals and quantification of the impacts of greenhouse gas emissions. He has conducted and overseen numerous economic and bill impact assessments in support of projects and policy proposals, ranging from new power plants and transportation facilities to electric, petroleum, and natural gas transmission infrastructure.\n\n)\n\nProfessor Howell’s research focuses on entrepreneurship, private equity, fintech, and innovation. She is a research associate at the National Bureau of Economic Research, a fellow at the Asian Bureau of Finance and Economic Research, and a research fellow at the Institute for Private Capital’s Private Equity Research Consortium. She has testified before the US House Committee on Ways and Means and presented her work before the US Department of Energy, Senate Committee on Small Business and Entrepreneurship, Air Force, and Centers for Medicare & Medicaid Services. Professor Howell is the recipient of the AQR Asset Management Institute Young Researcher Award and the Kauffman Foundation Junior Faculty Research Fellowship, among other awards. She also serves as an associate editor of The Review of Financial Studies and a member of the advisory board to the American Female Finance Committee of the American Finance Association. Earlier in her career, Professor Howell was an energy security policy analyst and an energy consultant.\n\n)\n\nProfessor Goodwin is an expert in applied econometrics and the economics of the food system. He has conducted research on a wide variety of agricultural markets, including wheat, corn, soybeans, cattle, swine, dairy products, and eggs. He has published extensively in the areas of price and demand analysis, market definition, food marketing, agricultural policy, crop insurance and risk management, international trade, and applied econometrics, and his work is widely cited by other economists. In 2006, Professor Goodwin was elected a fellow of the Agricultural & Applied Economics Association (AAEA), and in 2014 he was elected to serve as president of the AAEA. Prior to joining North Carolina State, Professor Goodwin was on the faculties of Kansas State University and the Ohio State University, where he held the Andersons Endowed Chair.\n\nProfessor Goodwin has served as an expert witness in federal and state court proceedings. He has consulted on a number of projects for public and private organizations, including Bayer CropScience, the Federal Crop Insurance Corporation, Monsanto, Syngenta, Aon-Benfield, Oxfam America, the World Bank, the Organization for Economic Cooperation and Development, and the Risk Management Agency of the US Department of Agriculture.\n\n)\n\nMs. Okie has conducted economic and financial analyses and managed case teams in support of academic and industry experts across engagements in securities and antitrust litigation, regulatory investigations, bankruptcy matters, arbitrations, and general commercial litigation. Her experience spans a wide variety of sectors and has included fact and expert discovery, class certification, liability and damages, and trial. Her antitrust work includes civil and criminal litigation surrounding a variety of alleged anticompetitive conduct and analyses of competition issues across a range of industries. Ms. Okie has worked on a number of matters at the intersection of antitrust and financial services, including alleged anticompetitive conduct related to foreign exchange rates, municipal bond markets, and financial product trading. She has assessed alleged misrepresentations and omissions in the underwriting of securities, including issues surrounding loss causation, falsity, materiality, and buy-side and sell-side due diligence; analyzed valuation issues in mergers and acquisitions; and evaluated REIT market corporate governance and industry dynamics. In the energy sector, Ms. Okie has estimated damages associated with failed projects; valued rights-of-way; and supported clients involved in market manipulation investigations by the US Department of Justice (DOJ), the Commodity Futures Trading Commission (CFTC), the Federal Energy Regulatory Commission (FERC), and state agencies. She has evaluated trading data, market power, and other competitive issues in oil, natural gas, propane, and electricity markets. Ms. Okie has published on many energy; environmental; and environmental, social, and governance (ESG) topics and authored white papers and reports for foundations, regional transmission organizations, and industry organizations. Ms. Okie is vice-chair of the Insurance and Financial Services Committee of the American Bar Association’s Antitrust Law Section.\n\n)\n\nProfessor Piggott is an expert in agricultural economics whose work focuses on demand analysis, agricultural markets, applied econometrics, agricultural biotech, and risk management. He has significant experience serving as an expert witness in agriculture-related litigation and has testified before the US Congress on the state of the farm economy and the impact of federal policy on US agriculture. He has consulted with companies such as Monsanto, Syngenta, RTI International, Centrec Consulting Group, the American Farm Bureau Federation, and federal agencies on demand for agricultural commodities and commodity promotion, the impacts of agricultural biotechnology, the US livestock industry, and the evaluation of crop insurance products.\n\nProfessor Piggott’s research, which has been published in leading peer-reviewed agricultural economics journals, has examined topics related to the impact of biotech on crop yields, consumer demand responses in the meat industry, the economics of biotech adoption, the development of new functional forms in demand analysis, risk management from infectious plant diseases, price transmissions in various meat markets, and integration among spatially separated commodity markets. He has received research awards from the American Agricultural Economics Association and the Food Distribution Research Society. Professor Piggott’s extension program, which received an award for excellence from the American Agricultural Economics Association, has involved nearly 200 workshops and seminars on grain marketing, agricultural outlook, and risk management strategies.\n\n)\n\nDr. Schatzki has a broad range of expertise in energy, environment, finance, and competition matters. He supports clients in a range of contexts, including strategic and financial advice, policy analysis, regulatory and rulemaking proceedings, and litigation.\n\nDr. Schatzki has deep experience in electricity, natural gas, petroleum, and renewable energy. His expertise in the electricity sector includes wholesale energy and capacity market design; utility regulation and ratemaking; economic impact analysis of new market rules, regulations, and generation and transmission investments; contract analysis and disputes; financial valuation; and options analysis. Dr. Schatzki has testified before US state and federal, as well as Canadian provincial, regulatory commissions. He has supported the analysis of alleged market manipulation and damages in high-profile litigations such as FERC v. Barclays and lawsuits following the California electricity crisis.\n\nDr. Schatzki works extensively on environmental economics, policy, and regulation. Recently, he has focused on the intersection of climate policy and energy markets, and disputes involving water resources and environmental contamination. His research has been published in distinguished energy- and environment-related publications, and he has provided research for prominent organizations such as the Electric Power Research Institute, the Edison Electric Institute, and the Federal Energy Regulatory Commission.\n\nIn finance and competition matters, Dr. Schatzki has worked with clients on litigation and non-litigation projects in many sectors, including energy, financial instruments, foreign exchange, insurance, airlines, and retail products.\n\n)\n\nDr. Zenner is an international expert in corporate finance and investment banking, with decades of industry and academic experience. He has provided trial and deposition testimony in federal and state courts, including the Delaware Court of Chancery. A former managing director for J.P. Morgan’s Investment Banking Division and former global co-head of Corporate Finance Advisory, Dr. Zenner has advised boards and senior executives across various industries and geographies on valuation, spinoffs, activism defense strategies, shareholder distributions, internal capital allocation, capital structure, potential strategic combinations, investor communication strategies, and risk and liquidity management. Before joining J.P. Morgan, he held positions as a managing director and global head of the Financial Strategy Group, a group within Citi’s Investment Banking Division; and as managing director and North America head of the Financial Markets Advisory Group, within ABN AMRO’s Financial Markets Division. He has extensive experience in the global energy sector; he is the former CFO and a current senior advisor of Persefoni, a SaaS (software as a service) platform that allows enterprises to manage their carbon footprints.\n\nPrior to his career in investment banking, Dr. Zenner was a professor of finance and chair of the finance and economics area at the UNC Kenan-Flagler Business School, where he won numerous teaching awards. He has published extensively, authoring over 100 practitioner reports and earning over 3,200 academic citations. Dr. Zenner was an associate editor and served three terms as practitioner board member for Financial Management. He has made over 100 board presentations on corporate finance issues and trends. Dr. Zenner has served as a board member of InnerWorkings, Sentinel Energy Services, and OneSpan, and as a senior advisor to verseAI.\n\n)\n\nProfessor Hubbard is a leading expert in public economics, corporate and institutional finance, macroeconomics, antitrust, and industrial organization. He has provided trial and deposition testimony in numerous litigation matters, including more than a dozen cases in the Delaware Chancery Court. He has also served as a testifying expert in several high-profile finance- and securities-related cases, as well as on damages issues in antitrust matters. Professor Hubbard has consulted to several government and international agencies, including the US Department of the Treasury, the US International Trade Commission, the US Securities and Exchange Commission, the World Bank, the Board of Governors of the Federal Reserve System, the Federal Reserve Bank of New York, and the Congressional Budget Office. From 2001 to 2003, he served as chairman of the President’s Council of Economic Advisers.\n\nProfessor Hubbard has published more than 100 scholarly articles and coauthored several books, including the widely used textbook Money, the Financial System, and the Economy. His commentaries have appeared in Businessweek, The Wall Street Journal, The New York Times, the Financial Times, and The Washington Post, as well as on PBS television and NPR radio business programs. A frequent speaker, Professor Hubbard has presented his research at economic conferences throughout the world.\n\n)\n\nDr. Signorovitch advises life sciences companies on data analytics for business critical research and decision making. He has broad experience leading the strategic development and implementation of analytics across the product life cycle, from early-phase clinical studies to market access and real-world evidence generation. Dr. Signorovitch’s practice areas span trial design, multi-stakeholder collaborations, natural history studies, regulatory interactions, health economic modeling, global reimbursement submissions, policy evaluation, real-world evidence development, individualized medicine, predictive analytics, and due diligence for acquisitions. He has particular expertise in developing and applying new methodologies to address health care research challenges, and in designing analytics platforms to enhance collaborative research and decision making. Dr. Signorovitch’s work has been used to inform clinical regulators and health care payers in US and global markets, published in peer-reviewed journals, and presented at clinical and economic research conferences. Prior to joining Analysis Group, Dr. Signorovitch was a research fellow at the Harvard-MIT Division of Health Sciences and Technology.\n\n)\n\nProfessor Kahn’s research interests include brand management and loyalty, consumer choice and decision making, price promotions, and retailing. She has served as an expert witness and testified at deposition in numerous matters. Professor Kahn is the author of Global Brand Power: Leveraging Branding for Long-Term Growth and The Shopping Revolution: How Retailers Succeed in an Era of Endless Disruption Accelerated by COVID-19, and coauthor of Grocery Revolution: The New Focus on the Customer. She has published more than 70 articles in leading academic journals. She is a former area editor of Marketing Science, the Journal of Consumer Research, the Journal of Consumer Psychology, and the Journal of Marketing, and has served on the editorial boards of the Journal of Marketing, the Journal of Marketing Research, Marketing Science, the Journal of Consumer Research, the Journal of Behavioral Decision Making, and Marketing Letters. Prior to joining The Wharton School, Professor Kahn was on the faculty of the UCLA Anderson School of Management. She also served as dean of the Miami Herbert Business School.\n\n)\n\nProfessor Grabowski specializes in health care economics, with a particular focus on insurance coverage and prescription drug markets and prices. He has testified before Congress on payment and quality issues in health care, and was the principal investigator on several research projects funded by the National Institute on Aging. He has also testified as an expert in a large pharmaceutical antitrust litigation matter, in which he explained how prescriptions are paid for. As a member of the Medicare Payment Advisory Commission (MedPAC), Professor Grabowski advised Congress on issues impacting the Medicare program. He has served as a technical expert for numerous organizations, including the Department of Health and Human Services (HHS), the US Centers for Medicare & Medicaid Services (CMS), and the National Institute on Disability and Rehabilitation Research. Professor Grabowski’s research on such topics as post-acute care payment models, Medicare hospital payment systems, and COVID policies in long-term care has been widely published in peer-reviewed journals as well as medical and mainstream media. Additionally, his work has earned support from numerous organizations, including the Robert Wood Johnson Foundation, the Commonwealth Fund, and the Donaghue Foundation. Professor Grabowski is a frequent speaker at national and international health economics conferences.\n\n)\n\nMs. Pike applies her expertise in health economics, statistics, and large administrative claims and transaction-level databases to help resolve complex litigation and strategic business questions in a variety of contexts, including matters involving the False Claims Act, Anti-Kickback Statute, and Controlled Substance Act. She has performed economic analyses and presented findings to US Attorney's Office investigators in numerous cases involving allegations of off-label promotion, kickback, and pricing issues. Ms. Pike also applies economic theory and empirical estimation methods in a variety of product liability, breach of contract, intellectual property, and transfer-pricing engagements. She has extensive experience in developing flexible damages models for real-time use in high-stakes negotiations.\n\nMs. Pike has been instrumental in developing bespoke suspicious order monitoring programs; building internal analytical programs to assess the risk of theft or diversion; and assisting manufacturers, wholesalers, and pharmacies in responding to government investigations and/or lawsuits related to controlled substance distribution and dispensing. She has managed a range of health care cases involving analysis of future lost profits; economic analysis of physician payment structures under capitation; studies of the cost effectiveness, budget impacts, and direct and indirect costs of illness associated with a variety of diseases; and pricing analyses for large multinational corporations across numerous industries. Ms. Pike has published numerous articles on related topics in health care economics and clinical journals.\n\n)\n\nProfessor Platt is an expert in biostatistics and pharmacoepidemiology, with a focus on developing statistical methods for causal inferences in observational studies. His recent research addresses both broad methodological topics in pharmacoepidemiology and statistical issues specific to perinatal epidemiology. Since 2011, Professor Platt has served as the leader of the methods team for the Canadian Network for Observational Drug Effect Studies, whose mandate is to provide high-quality evidence in response to drug safety queries generated by Canadian public health stakeholders. He was president of the Society for Pediatric and Perinatal Epidemiologic Research for two years, and continues to serve the society on its executive committee. Professor Platt is a past president of the Statistical Society of Canada. In addition, over a span of seven years he led and developed the Biostatistics Consulting Service and oversaw the amalgamation of biostatistics services under the Centre for Innovative Medicine and the Centre for Outcomes Research and Epidemiology at the Research Institute of the McGill University Health Center. Professor Platt is an active publisher and serves as an associate editor of multiple journals, including Statistics in Medicine and the American Journal of Epidemiology. He has participated in several national grant panels, including for the Canadian Institutes of Health Research (CIHR) and the National Cancer Institute of Canada (NCIC).\n\n)\n\nMr. Davis specializes in applying financial economics and data analysis to major litigation matters, with a focus on agricultural markets and pharmaceutical products. He has experience managing case teams, supporting academic affiliates and industry experts, and assisting clients through all phases of complex business litigation, including fact discovery, class certification, merits, trial, and settlement. Mr. Davis’s agricultural experience includes antitrust matters involving allegations of market power in animal protein markets, matters involving the presence of genetically modified products in US grain supplies, and matters involving international trade in agricultural products. His pharmaceutical work includes antitrust matters involving allegations of delayed generic entry, False Claims Act matters involving allegations related to the promotion of pharmaceuticals, and disputes pertaining to the commercial reasonableness of firm conduct.\n\nMr. Davis also has experience conducting economic research across a variety of industries, including financial services, agriculture, and pharmaceuticals, and analyzing issues related to commodity markets, futures prices, intellectual property and patents, industrial organization and antitrust law, and financial market infrastructure. He is a CFA charterholder.\n\n)\n\nProfessor Zervas specializes in quantitative marketing. His research lies at the interface of data science and economics, with a focus on empirical studies of online platforms and marketplaces. He has been retained to consult on matters involving significant data collection and analysis, as well as economic analysis. He has testified in litigation on various technical issues regarding digital platforms. In his research, Professor Zervas has studied the digitization of reputation, e-commerce, peer-to-peer marketplaces, and computational advertising. He has presented and published on topics such as the rise of the sharing economy – specifically, its impact on the hotel industry – and online reputation management. An associate editor of ACM Transactions on Economics and Computation, Professor Zervas has also served on the editorial review boards of Marketing Science, the Journal of Marketing Research, and the Journal of Marketing. Prior to joining the Boston University faculty, he held various academic roles, including as a visiting scholar at the MIT Sloan School of Management, as a Simons Postdoctoral Fellow at Yale University, and as an affiliate at the Center for Research on Computation and Society at the Harvard John A. Paulson School of Engineering and Applied Sciences. Prior to pursuing his Ph.D. in computer science, Professor Zervas ran a small information technology consultancy that provided software development services to a variety of clients.\n\n)\n\nProfessor Jena is a health economist, practicing internal medicine physician, and professor of health care policy. His work involves several areas of health economics and policy, including the economics of medical innovation, the economics of physician behavior and the physician workforce, medical malpractice, and the economics of health care productivity. Professor Jena has been retained as an expert in several pharmaceutical and health care industry matters.\n\nA prolific author, Professor Jena is the coauthor of the book Random Acts of Medicine, and he has contributed to more than 150 peer-reviewed articles and articles intended to increase patient understanding, published in outlets including The New England Journal of Medicine and The New York Times. He is a faculty research fellow at the National Bureau of Economic Research and serves on Harvard Medical School’s Standing Committee on Health Policy. Professor Jena is a recipient of the NIH Director’s Early Independence Award to fund research on the physician determinants of health care spending, quality, and patient outcomes, and a recipient of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) New Investigator Award. In 2018, he was listed among 100 great leaders in health care by Becker’s Hospital Review.\n\n)\n\nMs. Pinheiro has an extensive background in quantitative analysis and data science, which she has applied to various practice areas, including finance, intellectual property, biostatistics, and antitrust. In finance, she focuses on cases involving allegations of market price manipulation, misleading communications, excessive mutual fund fees, and mortgage-backed securities litigation. In particular, she has been retained by the US Department of Justice, regulatory agencies, banking institutions, and market exchanges to consult, advise, and testify on matters involving allegations of spoofing and price manipulation, as well as corresponding detection approaches. She has also applied survey analysis and statistical modeling to various intellectual property cases, including patent disputes among smartphone manufacturers, copyright tariff setting for musical works, and patent infringement in the pharmaceutical industry. She has extensive experience analyzing clinical trial, registry, and insurance claims data for both litigation and research purposes and has published manuscripts on pharmacoeconomic issues. In the antitrust field, she has acted as an expert and supported other experts in class certification and price-fixing matters involving a wide range of industries, including online search engines, computer chips, liquid-crystal display (LCD) panels, airline ticketing services, gaming, and grocery stores. Ms. Pinheiro has also authored expert reports and testified on questions relating to the modeling and calculation of royalties and damages.\n\nPrior to joining Analysis Group, Ms. Pinheiro served as executive director of the finance group of CIRANO, where she conducted applied research projects in collaboration with private and public partners, including work on hedge funds, style analysis, credit and operational risk, and the development of integrated risk management tools for practical applications.\n\nRead Lisa’s profile\n\n)\n\nWith more than 40 years of experience in financial services and real estate, Mr. Allen specializes in residential mortgage backed securities (RMBS), international real estate, and banking laws and regulations. He has provided depositions and directed litigation projects for some of the largest RMBS cases, on the topics of valuations, appraisals, Uniform Standards of Professional Appraisal Practice (USPAP), laws and regulations, and automated valuation models (AVMs). He also developed the first collateral risk scoring system that combines credit and collateral data to evaluate quality control and fraud prevention using advanced algorithms. Mr. Allen has provided diplomatic relations advice and assistance to central banks and other government agencies related to financial services and real estate, including the development and implementation of laws and regulations in many areas of the world – such as Eastern Europe, Asia, the Caribbean, and North Africa. He has worked with various organizations including the US Treasury Office of Technical Assistance (OTA), the International Monetary Fund (IMF), and the World Bank. Mr. Allen is a frequent speaker on AVMs, appraisal principles and techniques, and federal banking regulations for organizations such as the American Bar Association, Mortgage Bankers Association, and Federal Financial Institutions Examination Council.\n\n)\n\nMr. Deal leads the economic analyses in the Menlo Park, California office and helps coordinate the firm’s Insurance practice. He combines an economics and risk analysis background with many years of experience in economic, litigation, and management consulting. He serves as a testifying and consulting expert on a wide variety of matters, often involving economic and statistical analysis of large datasets. His work as an expert has covered a variety of practice areas, including antitrust, economic damages, class action matters, and business valuation. Mr. Deal’s experience includes work in health care, insurance, finance, technology, and many other industries. He has coauthored a number of book chapters and studies, including The Economic Effects of Federal Participation in Terrorism Risk with R. Glenn Hubbard, an Analysis Group academic affiliate, former chair of the President’s Council of Economic Advisers, and former dean of the Columbia Business School.\n\n)\n\nProfessor Slottje has deep experience in both academia and economic consulting. An emeritus professor of economics at Southern Methodist University, he has been working in litigation consulting for more than three decades in senior positions with several international firms. He has worked with many leading law firms, testifying at deposition and trial in hundreds of prominent matters.\n\nAn economist and a statistician, Professor Slottje is an expert in the fields of labor economics, consumer demand, industrial organization, and statistics and econometrics, allowing him to bring a unique perspective and skill set to his consulting assignments. He has published more than 150 journal articles and more than a dozen books, and has been ranked among the world’s top three scholars in applied econometrics based on his publishing record in the field. Professor Slottje is a member of the American Economic Association, the American Statistical Association, and The Econometric Society.\n\n)\n\nMr. Porten is a Chartered Financial Analyst and investment expert with more than 30 years of experience in portfolio management of hedge funds and mutual funds, as well as due diligence procedures and fund compliance issues. He is familiar with the laws, regulations, and professional standards governing portfolio management and brings an extensive knowledge of broker-dealer, registered investment advisor, and bank trust environments. In investment-related litigation matters, he has examined portfolios for compatibility with investors' stated risk profiles and has sought to identify fiduciary improprieties by investment advisors, broker-dealers, and trustees. As an expert, he has been retained by the US Securities and Exchange Commission, and has testified on behalf of major financial institutions and plaintiffs regarding fiduciary duty, analyst responsibilities, standards of care, due diligence, suitability, and supervision with respect to products such as mutual funds, hedge funds, ERISA accounts, and trust and investment portfolios. Mr. Porten's background includes senior roles at several leading financial institutions, including chief investment officer at both Citibank and IBJ Schroder Bank & Trust, and portfolio manager at Neuberger Berman.\n\n)\n\nMs. Kamerick is an expert in corporate governance, corporate finance, securities law, and mergers and acquisitions (M&A). She has held CFO positions at a number of prominent firms – including BP Amoco (Americas), Heidrick & Struggles, and Houlihan Lokey – and served as a senior financial and legal advisor to major multinational corporations. Ms. Kamerick is a former M&A and securities attorney with Skadden, Arps, Slate, Meagher & Flom. She has significant experience overseeing 401(k) and defined-benefit retirement plans, and chairing defined-benefit retirement plan investment committees. In addition to consulting on financial, strategic, and corporate governance matters, Ms. Kamerick serves on several boards, frequently acting as chair of the audit committee and as the board’s Securities and Exchange Commission (SEC) financial expert. She also serves on the boards of the Legg Mason Closed-End Mutual Funds and the AIG Funds & Anchor Series Trust (a mutual fund complex). Ms. Kamerick is a National Association of Corporate Directors (NACD) Board Leadership Fellow and holds the NACD Directorship certification. She has held several adjunct professorships and lectured on corporate governance and fiduciary duties at numerous universities, as well as in NACD’s Battlefield to Boardroom program for flag officers. Ms. Kamerick is a frequent contributor to Agenda and Directors & Boards. She serves on the Alzheimer’s Association board of directors, as well as its audit and finance committees. In 2020, she was a judge for IR Magazine’s Corporate Governance Awards.\n\n)\n\nProfessor Powers specializes in data privacy and cybersecurity policy and law. In his work, he draws on more than 20 years of combined legal, business, data privacy and security, national security, law enforcement, military, and academic experience. Professor Powers has served as an analyst and attorney for the US Department of Justice, the US Navy, the US Department of Defense, and a number of law firms, and as general counsel for an international software company. He regularly consults to government and private entities on data privacy and security programs; cybersecurity audits and assessments; cybersecurity strategies, risk, compliance, and frameworks; incident planning and response; and government investigations. Professor Powers created and oversees courses and certificates for Boston College’s graduate cybersecurity programs, including the Data Privacy: GDPR & HIPAA professional certificate program, and the Cybersecurity Policy: Privacy and Legal Requirements course. He is a member of the Boston College Law School Business Advisory Council and has provided expert commentary regarding cybersecurity, data privacy, and national security concerns for a wide variety of media outlets. Prior to joining Boston College, Professor Powers taught courses at the US Naval Academy. Previously, he was the panel lead for the Collegiate Working Group for the US Department of Homeland Security’s National Initiative for Cybersecurity Education. Professor Powers is a research affiliate at the MIT Sloan School of Management.\n\n)\n\nMs. Resch has extensive experience consulting on finance, financial economics, and accounting issues in complex litigations and arbitrations, with a particular focus on international arbitration. She is a testifying expert, specializing in the quantification of economic damages in both international arbitration and litigation. Ms. Resch has advised on valuation issues such as cost of capital and valuation discounts and premia. Her damages and valuation work has spanned disputes over complex financial instruments; oil and gas contracts; government expropriation matters; and shareholder disputes throughout the UK, Russia, Central Asia, and South America in both commercial arbitration and investment treaty arbitration. She has also consulted on state aid proceedings in the banking industry and provided damages assessments in litigation matters before the UK High Court of Justice. Prior to joining Analysis Group, Ms. Resch was a partner and co-founder of an economics consulting firm.\n\n)\n\nProfessor Knittel’s research focuses on industrial organization, applied econometrics, and energy and environmental economics. He has provided trial and deposition testimony in a number of litigation matters, including valuing product features in smartphones, PCs, and contact lenses. He has also consulted to Delta Airlines, Ford Motor Company, the US Energy Information Administration, and Korea Electric Power Company. Professor Knittel has authored or coauthored numerous articles on topics such as market structure and product pricing, tacit collusion, and challenges in merger simulation analysis. Examples of his research include articles on the spurious correlation between ethanol production and gasoline prices, unilateral market power in the electricity reserves market, and tacit collusion in credit card markets. His research has appeared in the American Economic Review, the American Economic Journal: Macroeconomics, the American Economic Journal: Economic Policy, The Review of Economics and Statistics, The Journal of Industrial Economics, and The Energy Journal, among other academic publications. He is a former coeditor of the Journal of Public Economics and serves or has served as an associate editor for several other scholarly journals, including the American Economic Journal: Economic Policy, The Journal of Industrial Economics, the Journal of Transport Economics and Policy, and The Journal of Energy Markets. Professor Knittel is a research associate at the National Bureau of Economic Research (NBER) in the Productivity, Innovation, and Entrepreneurship and Industrial Organization programs, and he co-directs the Environment and Energy Economics program.\n\n)\n\nMr. Decter specializes in the application of microeconomics, finance, and data analysis to complex securities and antitrust litigation and business strategy cases, most notably in matters related to residential mortgage-backed securities, collateralized debt obligations and credit default swaps, residential mortgage lending, mortgage reinsurance, commercial insurance, private equity, and payment cards. He has conducted damages analyses, and supported multiple experts in the areas of statistical sampling, loan and securities underwriting, damages, and loss causation.\n\nMr. Decter's business litigation experience focuses on finance matters in which he has managed large case teams and data sets in working with testifying experts. He supported academic affiliates in their examination "
    }
}